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Introduction
The gene causing familial Mediterranean fever (FMF),
MEFV, encodes a protein, pyrin, which is expressed at
high levels in granulocytes, monocytes, dendritic cells and
in some human myeloid leukemia cell lines, such as
THP.1. Studies of pyrin localization show a cell-type
dependency. In transfection experiments full-length pyrin
is cytoplasmic and associates with the cytoskeleton. How-
ever, native pyrin is predominantly nuclear in granulo-
cytes, dendritic cells, and synovial fibroblasts, but it is
cytoplasmic in monocytes. Recent studies have implicated
pyrin in the regulation of IL-1b and NFΚB activation.
Objectives
To provide additional molecular insight into pyrin
function.
Methods
RNA interference (RNAi) technique coupled with Affy-
metrix cDNA microarray analysis was employed to com-
pare gene expression profiles between the human
myeloid leukemia cell line, THP.1, expressing endogen-
ous pyrin (scrambled control, SC) and cells in which the
gene had been knocked down (siMEFV). Western blot
and qRT-PCR analysis was used for validation. Promoter
analysis was used to investigate the possibility of a com-
mon regulator among the subset of genes identified.
Chromatin immuno-precipitation (CHiP) followed by
quantitative PCR (qPCR) was used to validate binding.
Results
We identified over 300 genes differentially expressed in
siMEFV treated cells compared to (SC) with 1.4 fold dif-
ference and p < 0.05. Based on novelty and gene func-
tion, 10 down-regulated genes (CD36, LY96, S100A8,
CCR1, CD53, TIRAP, DEDD, SGK, MyD88, CD14) were
identified for further study. Using total RNA and protein
from independent siRNA experiments, 7 of 10 genes
showed a comparable mRNA and protein alteration con-
sistent with microarray analysis. To investigate if the
genes were being regulated by a common transcription
factor, promoter analysis was used. We found that these
genes showed enrichment of a binding site for interferon
regulatory factors (IRFs, p=0.03). Additional screening of
the 9 family members identified IRF2 as the most signifi-
cantly changed IRF transcription factor with a fold
change of -3.4 and a p value of 0.008. Consistent with
the computational analysis, siMEFV treated cells showed
diminution in IRF2 mRNA and protein compared to SC.
Our previous studies identified MEFV as an interferon
gamma (IFNg) immediate early gene after IFNg stimula-
tion in monocytes. Thus, we decided to examine the pos-
sibility that pyrin could directly regulate IRF2. Using
CHiP-qPCR to test this hypothesis, we demonstrated
binding of pyrin within the promoter of IRF2.
Conclusion
Our findings suggest that in THP1 cells pyrin might
regulate expression of innate immune genes by binding
to the promoter of the transcription factor IRF2. Further
research is needed to examine the possibility that pyrin
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